Curevac
A biopharmaceutical company developing therapies based on messenger RNA (mRNA) technology.
CVAC | F
Overview
Corporate Details
- ISIN(s):
- NL0015436031
- LEI:
- 724500BUT8GAG9LMYN56
- Country:
- Germany
- Address:
- Friedrich-Miescher-Strasse 15, 72076 Tübingen
- Website:
- https://www.curevac.com/en/
- Sector:
- Manufacturing
Description
CureVac is a global biopharmaceutical company specializing in the development of therapies based on messenger RNA (mRNA) technology. With over two decades of experience, the company engineers mRNA as a data carrier to instruct the human body to produce its own therapeutic proteins to combat a wide range of diseases. Its development pipeline focuses on creating transformative medicines, including prophylactic vaccines for infectious diseases and other therapeutic applications. CureVac collaborates with partners like GSK to advance its high-value mRNA programs, such as its seasonal influenza vaccine candidate.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-26 00:46 |
CureVac Announces Voting Results of Extraordinary General Meeting
|
English | 20.3 KB | ||
| 2025-11-24 13:10 |
CureVac Announces Financial Results for the Third Quarter and First Nine Months…
|
English | 72.8 KB | ||
| 2025-08-15 13:27 |
CureVac Announces Financial Results for the Second Quarter and First Half of 20…
|
English | 25.8 KB | ||
| 2025-08-08 02:15 |
CureVac Announces Resolution of Patent Litigation with Pfizer/BioNTech
|
English | 11.5 KB | ||
| 2025-06-24 22:09 |
CureVac Announces Voting Results of General Meeting
|
English | 10.0 KB | ||
| 2025-05-20 13:00 |
CureVac Announces Financial Results for the First Quarter of 2025 and Provides …
|
English | 23.3 KB | ||
| 2025-05-15 22:10 |
CureVac Receives Additional Positive Validity Decision from European Patent Off…
|
English | 12.1 KB | ||
| 2025-04-10 13:12 |
CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2024 a…
|
English | 39.8 KB | ||
| 2025-04-09 13:00 |
CureVac to Report Fourth Quarter and Full-Year 2024 Financial Results and Busin…
|
English | 10.4 KB | ||
| 2025-04-07 13:00 |
CureVac Receives U.S. FDA IND Clearance to Initiate Phase 1 Clinical Trial for …
|
English | 14.7 KB | ||
| 2025-03-27 21:05 |
CureVac Receives Positive Validity Decision from European Patent Office in Liti…
|
English | 11.9 KB | ||
| 2025-02-19 13:03 |
CureVac Earns Repeat Recognition by LexisNexis as One of the Worlds Top Innovat…
|
English | 12.2 KB | ||
| 2025-02-18 13:03 |
CureVac Earns Repeat Recognition by LexisNexis as One of the Worlds Top Innovat…
|
English | 12.2 KB | ||
| 2024-04-25 00:00 | English | 4.3 MB |
Automate Your Workflow. Get a real-time feed of all Curevac filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Curevac
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Curevac via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
